PD43-10 HOW OFTEN DOES CISPLATIN INELIGIBILITY PREVENT PATIENTS FROM RECEIVING ADJUVANT THERAPY FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA?